We are live on ! Find out more
AC

Axon Capital Portfolio holdings

AUM $69.3M
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$47.6M
AUM Growth
+$4.36M
Cap. Flow
+$727K
Cap. Flow %
1.53%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
1
Reduced
Closed
3

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$5.57M
2
CNC icon
Centene
CNC
+$2.82M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.75M
2
MCK icon
McKesson
MCK
+$2.67M
3
EFX icon
Equifax
EFX
+$2.23M

Sector Composition

Rank Sector Weight
1 Communication Services 47.39%
2 Healthcare 30.65%
3 Consumer Discretionary 14.85%
4 Financials 7.11%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.59T
$8.42M 17.68%
50,500
CNC icon
2
Centene
CNC
$32.5B
$8.35M 17.54%
157,300
+46,500
+42% +$2.82M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.17T
$7.48M 15.7%
127,460
PLYA
4
DELISTED
Playa Hotels & Resorts
PLYA
$7.07M 14.85%
926,815
TSG
5
DELISTED
The Stars Group Inc.
TSG
$6.67M 14.01%
380,935
PTCT icon
6
PTC Therapeutics
PTCT
$6.5B
$6.24M 13.11%
+165,800
New +$5.57M
HDB icon
7
HDFC Bank
HDB
$119B
$3.38M 7.11%
116,800
EFX icon
8
Equifax
EFX
$20B
-23,990
Closed -$2.23M
MCK icon
9
McKesson
MCK
$95.3B
-24,212
Closed -$2.67M
AGN
10
DELISTED
Allergan plc
AGN
-20,600
Closed -$2.75M

Similar funds

Axon Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Axon Capital held 10 positions worth $47.6M, up 10% from $43.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Axon Capital's Q1 2019 filing shows 1 new, 1 increased and 3 closed positions. Its largest new stake was PTC Therapeutics: 165,800 shares worth $6.24M. The largest sale was Allergan plc, an estimated $2.75M.

By sector, the portfolio is most concentrated in Communication Services at 47% of assets, up from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axon Capital's largest Q1 2019 buy was PTC Therapeutics: 165,800 shares worth $6.24M.
  • Axon Capital added most to Centene in Q1 2019, an estimated $2.82M increase.
  • Axon Capital fully exited Allergan plc in Q1 2019, selling an estimated $2.75M.
  • Axon Capital's ten largest holdings make up 100% of its $47.6M portfolio in Q1 2019.
  • Axon Capital opened 1 new position and closed 3 in Q1 2019.
  • Axon Capital's portfolio value rose 10% quarter-over-quarter to $47.6M.

Based on Axon Capital's 13F filing for Q1 2019, filed 15 May 2019.